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ABSTRACT: Changes of intracellular Ca2+ concentration regulate many 
aspects of cardiac myocyte function. About 99% of the cytoplasmic 
calcium in cardiac myocytes is bound to buffers, and their properties will 
therefore have a major influence on Ca2+ signaling. This article considers 
the fundamental properties and identities of the buffers and how to 
measure them. It reviews the effects of buffering on the systolic Ca2+ 
transient and how this may change physiologically, and in heart failure 
and both atrial and ventricular arrhythmias, as well. It is concluded that 
the consequences of this strong buffering may be more significant than 
currently appreciated, and a fuller understanding is needed for proper 
understanding of cardiac calcium cycling and contractility.
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The importance of changes in intracellular calcium concentration in cardiac function needs little introduction (see1,2 for reviews). The systolic rise of ion-ized cytoplasmic calcium concentration ([Ca2+]i) activates contraction and 
regulates many sarcolemmal ion currents and, thereby, the electrophysiology of 
the cell; abnormal Ca2+ handling is implicated in the genesis of arrhythmias. Calci-
um is also a major factor in the control of gene expression. Work using fluorescent 
Ca2+ indicators has demonstrated how alterations of Ca2+ fluxes into the cytoplasm 
underlie the changes of contractility in health and disease. It is often overlooked, 
however, that only ≈1% of cytoplasmic Ca2+ is free, with the remainder being 
bound to cytoplasmic buffers.3 Therefore, the properties of these buffers will po-
tentially play as large a role as Ca2+ fluxes do in determining the size and kinetics 
of changes of [Ca2+]i.
Here we review recent progress in characterizing cytoplasmic buffers and their 
effects on the physiology of cardiac muscle, and disease mechanisms, as well. It is 
important to note that we also highlight the numerous areas where more work is 
required.
PROPERTIES OF INTRACELLULAR Ca2+ BUFFERS
Chemistry and Kinetics of Ca2+ Binding
Calcium (Ca2+) has several chemical features that make it a ubiquitous second mes-
senger.4,5 It forms a chemically active divalent cation in aqueous solution with an 
ionic radius larger than the other common divalent ion (Mg2+) resulting in higher-
affinity binding. The fact that its intracellular concentration is much lower than ex-
tracellular permits large changes of concentration because of sarcolemmal fluxes. 
Ca2+ binding alters the tertiary structure of proteins with consequences for their 
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catalytic activity. This is a reciprocal interaction because 
binding also resists changes of the free concentration 
of an ion by acting as a buffer.
The formation of several coordinate bonds between 
single Ca2+ ions and ligands is known as chelation. The 
electrons for these bonds typically come from nitrogen 
or oxygen atoms, replacing water molecules in the sol-
vation sphere of the Ca2+ ion with a series of bonds 
(usually 6) in a claw-like or chelation arrangement 
(Figure 1A). For example, EDTA is an organic chelator 
designed to bind divalent cations with very high affin-
ity. The EF hand, a helix-loop-helix configuration, is the 
most common Ca2+ binding motif in proteins.6 EF hand 
sites generally occur in pairs, and their affinity for Ca2+ 
and Mg2+ depends on the amino acids used to form 
the coordinate bonds, and the surrounding protein en-
vironment, as well. For example, calmodulin has 4 EF 
hand domains: (1) a high-affinity site that is normally 
bound at resting Ca2+ concentrations with a dissocia-
tion constant (Kd) of ≈100 nmol/L, (2) 2 further binding 
sites on the C terminal with Kd values of ≈300 nmol/L.
7 
The fourth binding site has the lowest affinity (Kd=10 
µmol/L) and therefore binds negligible Ca2+ within the 
physiological range (0.1–1 µmol/L). It may have a role 
in controlling enzymes located near sarcoplasmic reticu-
lum Ca2+ release sites in cardiac cells where [Ca2+]i rises 
to ≈100 µmol/L.7,8
The speed of the chelation reaction depends on its 
complexity (Table). The fastest binding occurs with small 
molecules (molecular weight <1000) such as BAPTA or 
Ca2+ indicators (eg, Fura-2 or Fluo-3), with a forward 
rate constant that approaches the diffusion-controlled 
limit (minimally 108 mol-1·L·s-1).17 Ca2+ binding to the 
EF hand structure of the regulatory site of troponin C 
is slightly slower.9 With even more complex reaction 
schemes (Figure 1B) that involve displacement of ions 
(eg, H+ or Mg2+) before Ca2+ binding, the kinetics slows 
considerably. For example, Ca2+ binding to the chelator 
EGTA requires dissociation of protons from intermedi-
ate forms of the ligand, reducing the overall forward 
rate constant (Table).18 Different forms of the EF hand 
motif, such as the Mg2+ sites of myosin, troponin C 
(TnC), and parvalbumin, have high relative affinities for 
Mg2+ that result in significant Mg2+ bound under physi-
ological conditions.19 The need for Mg2+ to dissociate as 
part of the equilibration results in a low apparent rate 
constant of Ca2+ binding.
Ca2+ Binding Sites in Cardiac Muscle
Based on previous work,3,11,20 the Table lists the major 
Ca2+ binding ligands, their estimated cytoplasmic con-
centrations, and dissociation constants (Kd) alongside 
estimates of the rate constants of Ca2+ binding. The 
ligands that bind appreciable amounts of Mg2+ under 
physiological conditions are grouped separately. The 
steady-state Ca2+ binding for several buffers as a func-
tion of [Ca2+] is shown in Figure 2Ai. The 2 major con-
tributors to buffering are TnC and sarcoplasmic reticu-
lum Ca2+ ATPase pump (SERCA).
Figure 1. Chemistry of Ca2+ binding to 
buffers.  
A, Schematics showing Ca2+ in various environ-
ments: water (i), bound to EDTA (ii), and bound 
to an EF hand (iii). B, Reaction schemes for 
Ca2+ binding to various buffers: simple binding 
(i), competition with Mg2+ (ii), and competition 
with protons (iii).
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Troponin C
TnC has 2 classes of Ca2+ binding sites (Figure 2A): (1) 
a single, lower-affinity, regulatory site that modulates 
myofibril activation and thence force; and (2) 2 high-
affinity sites that can also bind Mg2+, the Mg2+ sites. 
There is ample evidence that the affinity for Ca2+ of the 
regulatory site changes in various situations. For exam-
ple, acidification decreases the binding of Ca2+.21 Work 
using a fluorescent TnC showed that phosphorylation 
of troponin I, as occurs during β-adrenergic stimula-
tion, shifts the relationship between fluorescence and 
[Ca2+]i to higher [Ca
2+]i, indicating decreased Ca
2+ af-
finity. A similar approach has shown that troponin and 
tropomyosin mutations affect Ca2+ affinity,22 and such 
mutations have been directly shown to affect Ca2+ buff-
ering.23,24 It should, however, be noted that there are 
many circumstances (see below for discussion of heart 
failure) where the only available data are of a shift in 
the relationship between [Ca2+]i and force. It is often 
not certain whether this shift results from a direct effect 
on Ca2+ binding or a subsequent step in the contraction 
mechanism.25 For example, caffeine shifts the relation-
ship to lower [Ca2+]i but this effect is not accompanied 
by increased Ca2+ binding.26 Finally, much less is known 
about the properties of the Mg2+ site on troponin than 
the regulatory one. One issue, which also applies to 
other cellular buffers, is that studies of Ca2+ binding are 
generally performed in vitro using artificial solutions as 
opposed to cytoplasm. Given that many cellular constit-
uents may affect the properties of this important buffer, 
it is important to characterize Ca2+ binding to the Mg2+ 
sites under more physiological conditions. These sites 
can be mutated, and normal contraction requires only 
1 of the 2 Mg2+ sites.27 It would be interesting to know 
the effects on cardiac function and Ca2+ cycling of the 
expected large decrease of Ca2+ buffering.
Sarcoplasmic Reticulum Ca2+ ATPase Pump 
The inclusion of SERCA as a buffer emphasizes that it 
has 2 roles in decreasing cytoplasmic [Ca2+]i.
28 Initial 
buffering by binding is followed by active sequestra-
tion. In rabbit ventricle, systole involves an increase of 
≈60 µmol/L total Ca2+ resulting in a rise of free [Ca2+]i of 
≈0.6 µmol/L. Because of the affinity of SERCA binding 
sites, ≈30 µmol/L binds immediately and, with a peak 
uptake rate of ≈200 µmol·L–1·s–1, only ≈2 pump cycles 
are required to sequester the Ca2+ associated with a 
Ca2+ transient. This emphasizes the importance of the 
initial binding/buffering by SERCA in addition to its 
turnover in determining the rate of decay of the cyto-
plasmic Ca2+ transient.29
Other Ligands 
One important distinction is whether the buffers are 
immobile, or can diffuse. The Table gives values for the 
fixed sarcolemmal binding sites. The highly diffusible 
ATP binds Mg2+ and Ca2+ with moderately fast kinet-
ics, but, although present at 5 mmol/L, its low affin-
ity results in only a modest contribution to buffering. 
Other diffusible ligands include creatine phosphate 
and histidyl dipeptides that also bind Ca2+ and Mg2+. 
In heart, the predominant forms of this latter group of 
compounds include homocarnosine and anserine with 
a total concentration of ≈20 mmol/L.15 The affinities of 
Ca2+ and Mg2+ for these histidyl dipeptides  are lower 
than that of ATP, and together they constitute the bulk 
of the diffusible Ca2+ buffers. One feature of diffusible 
Ca2+ buffers is their ability to increase the apparent dif-
fusion coefficient of Ca2+ through diffusion of the Ca-
bound form.30 The histidyl dipeptides  are also weak 
acids and contribute to the pH buffer power of the cy-
tosol, thereby linking intracellular pH and Ca2+ buffer-
ing (see below).
Buffer Kinetics 
The importance of the different kinetics of the major 
buffers is illustrated in Figure 2Bi. The amount of Ca2+ 
bound to the regulatory site of TnC lags slightly behind 
free [Ca2+]. The lag is much greater for the slower buf-
fers (here the Mg2+ sites of myosin and TnC) and this 
is emphasized in the normalized data of Figure  2Bii. 
During a train of stimuli (Figure  2C), the slow kinet-
Table. Concentration and Properties of the Major Cellular Buffers in 
Ventricular Myocytes
Buffers
Concentration
µmol/L Cell 
Cytoplasm
Kd
µmol/L
On Rate
mol–1·L·s–1
Ca buffers
 Troponin C 
(regulatory)9,10
70 0.6 3.27×107
 SERCA11 47 0.6 1.00×108*
 Calmodulin3 24 7 3.4×107
 Sarcolemma (low)12 42 13 1.0×108*
 Sarcolemma (high)12 15 0.3 1.0×108*
Ca/Mg buffers
 Troponin C (Mg)9,13 140 0.0195 3.3×103
 Myosin9 140 4.62 9.6×104
 ATP14 5000 1200 1.9×106
 Histidyl dipeptides15,16 20 000 1000 6.1×106
Chemical probes
 BAPTA17  0.178 5.0×108
 EGTA18 (pH7.2) 0.180 2.3×106
The cellular buffers are organized in 2 groups: top, Ca buffers, and middle, 
Ca/Mg buffers. The properties of 2 chemical agents (BAPTA and EGTA) are 
shown below. For the cellular buffers, the first 2 columns show the buffer 
concentration and its Kd. The third column gives the value of the on rate 
constant for Ca2+ binding to the buffer. This has been calculated under standard 
conditions (initial free [Ca2+] 100 nmol/L, addition of 10 µmol/L Ca2+ to 10 
µmol/L buffer). The value for calmodulin is an approximation to 1 binding site.11 
For the Mg/Ca buffers and EGTA, the Kd and rate constant have been corrected 
for the apparent value in the presence of a cellular Mg2+ of 0.5 mmol/L. SERCA 
indicates sarcoplasmic reticulum Ca2+ ATPase pump.
*Indicates rate constant was estimated based on diffusion limit.
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ics of these buffers results in a beat-to-beat increase of 
bound Ca2+. Even at 1.5 Hz, these 2 slow sites together 
accumulate a total of ≈10 µmol/L Ca2+ and, at higher 
rates, when diastolic [Ca2+]i increases, greater binding 
is to be expected.
MEASUREMENT OF Ca2+ BUFFERING
As discussed above, buffering depends on the summed 
effects of a variety of Ca2+ binding molecules. It is of-
ten convenient to approximate this with a composite 
buffer value described by a single dissociation constant 
and ligand concentration. The simplest method is by 
titration. Solaro et al31 studied isolated cardiac myo-
filaments and calculated that about 22 µmol of Ca2+ 
per kg heart is required to produce 50% maximum 
contraction. This was accompanied by a rise of free 
Ca2+ of ≈1.4 µmol/L, indicating that the myofilaments 
alone can bind >90% of the total Ca2+. A subsequent 
approach, using cardiac homogenates, found that to 
raise free [Ca2+] to 1 µmol/L required 72 µmol/kg to-
tal Ca2+.32 Hove-Madsen and Bers33 performed similar 
experiments using permeabilized cells. This removed 
complications of extracellular components and allowed 
study of mitochondrial and sarcoplasmic reticulum (SR) 
buffering separately from cytoplasmic. They found that 
cytoplasmic buffering could be described by a Kd of 
0.42 µmol/L, plus a much lower-affinity component 
(Kd=79 µmol/L).
The methods described above involve destruction of 
the cell membrane. It is also important to be able to 
measure buffering under physiological conditions. This 
was first done by depolarizing ventricular myocytes 
and measuring the total entry of calcium through the 
L-type Ca2+ current20,34 under conditions in which Ca2+ 
removal mechanisms were inhibited (see Figure 3A and 
3B). Berlin et al34 compared Ca2+ entry with the rise 
of [Ca2+]i, giving a Kd of 0.96 µmol/L and a maximum 
buffer capacity of 123 µmol/L. A related method com-
pared the entry of Ca2+ through sodium calcium ex-
change (NCX) with [Ca2+]i as estimated indirectly from 
changes of cell length.37 A limitation of the method 
of Berlin et al is that it requires the irreversible SERCA 
inhibitor thapsigargin, precluding repeated measure-
ments before and after other interventions. An alter-
native approach uses rapid application of caffeine to 
release calcium from the SR resulting in an abrupt in-
crease of [Ca2+]i which then decays as NCX removes 
Ca2+ from the cell. Integrating the NCX current gives 
a measure of the change of total Ca2+ concentration 
Figure 2. Properties of cellular cardiac Ca2+ buffers.  
Ai, Steady-state Ca2+ buffering showing the dependence of bound on free Ca2+. The colored curves show the contributions of the 2 Ca2+ binding sites (regulatory 
[Reg] and Mg) of TnC, myosin, and SERCA. The solid black line shows the total, calculated as the sum of these components and the others listed in the Table. The 
dotted black line represents the sum of the fast buffers (top part of Table). ii, Buffer power (calculated as in equation 2) as a function of [Ca2+]i. B, Time course 
of change of bound [Ca2+] in response to systolic Ca2+ transients applied at 1.5 Hz. i, Absolute levels of [Ca2+]. The dashed line shows free [Ca2+] and the colored 
traces show the concentration of the Ca2+-bound form of the various ligands. ii, Normalized concentrations to emphasize kinetics. C, The change of bound Ca2+ in 
response to a series of Ca2+ transients (not shown) applied at 1.5 Hz. SERCA indicates sarcoplasmic reticulum Ca2+ ATPase pump; and TnC, troponin C.
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that is compared continuously with the change of free 
[Ca2+]i to characterize buffers
36 (Figure 3C through 3E). 
The caffeine response typically decays with a time con-
stant of 1 to 2 s38 so this cannot detect slower buf-
fers. In ferret ventricular myocytes, this method gave 
a Kd of 0.59 µmol/L with a maximum capacity of 114 
µmol/L cell equivalent to 175 µmol/L cytoplasm36 and, 
in rat ventricular myocytes, a Kd of 0.49 µmol/L and a 
maximum capacity of 149 µmol/L cytoplasm.39 This is 
stronger Ca2+ buffering than that found by Berlin et 
al.34 This may be because, in part, the caffeine method 
includes buffering by SERCA because thapsigargin is 
not present. Consistent with this, addition of thapsi-
gargin has been shown to decrease buffer power.40
BUFFERING AND THE SYSTOLIC Ca2+ 
TRANSIENT
Alterations of buffering power affect the systolic Ca2+ 
transient and thence contraction. Incorporation of Ca-
sensitive indicators has the side effect of increasing Ca2+ 
buffering, and this decreases systolic and increases dia-
stolic force, and slows the rate of mechanical relaxation, 
as well.41,42 Subsequent work found a decrease of both 
the amplitude and rate constant of decay of the Ca2+ tran-
sient because, the higher the buffer power, the smaller 
the change of free [Ca2+] resulting from a given rate of 
Ca2+ pumping.43 Adding exogenous buffer also decreases 
the rate of spontaneous beating of sinoatrial node cells, 
Figure 3. Measurement of buffering in intact cells.  
A, Comparison of the effects of Ca2+ influx through the L-type Ca2+ channel (bottom) with the resulting increase of [Ca2+]i. B, Relationship between the integral of 
the L-type Ca2+ current and the change of [Ca2+]i. Ca
2+ removal by SR, mitochondria, NCX, and PMCA were inhibited with thapsigargin, a mitochondrial uncoupler, 
Na-free solution and elevated external Ca2+ concentration, respectively. Figure reproduced from Bers35 from an original article34 with permission. Copyright © 2001, 
Kluwer Academic. C, Determination of Ca2+ buffering from the caffeine-evoked release of Ca2+ from the SR. Traces show (from top to bottom): [Ca2+]i, NCX cur-
rent, integral of current. Caffeine (10 mmol/L) was applied as shown by the bar. D, Relationship between total Ca2+ (estimated from the integral of NCX current) 
and [Ca2+]i. E, Separation of buffering into total, the contribution from the Ca-sensitive indicator (fluo-3) and the calculated intrinsic buffering of the cytoplasm. 
Reproduced from Trafford et al.36 NCX indicates sodium calcium exchange; PMCA, plasma membrane Ca2+ ATPase; and SR, sarcoplasmic reticulum. 
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presumably by decreasing the changes of [Ca2+]i that con-
tribute to pacemaker activity.44 In recent years, much work 
has been done using transgenic animals that express cal-
cium indicators. In principle, the additional buffering could 
be a concern, but it has been demonstrated that, at the 
concentrations expressed, this is not an issue.45
The effect of increased buffering also depends on 
the kinetics of the added buffer. Although fast buffers 
simply slow the Ca2+ transient, slower buffers produce 
a biphasic decay. The initial, fast phase reflects the time 
taken for cytoplasmic Ca2+ to bind to the buffer with 
the slower phase depending on the kinetics of Ca2+ re-
moval from the cytoplasm.43
It should be noted that, in the steady state, averaged 
over the cardiac cycle, Ca2+ efflux must equal influx. This 
efflux is determined by [Ca2+]i. If one assumes that Ca
2+ 
efflux is proportional to [Ca2+]i, then, in the steady state, 
the decrease of amplitude of the Ca2+ transient resulting 
from increased buffering must exactly balance the slow-
ing of decay of the transient and increased diastolic level 
such that the average level of [Ca2+]i is unaffected.
46,47 
Increasing stimulation rate will load cytoplasmic Ca2+ 
buffers (Figure 2C). An interruption of beating will result 
in this extra Ca2+ being taken up by the SR and then 
being available for release.23 This may affect contractil-
ity and (see below) contribute to Ca-dependent arrhyth-
mias. A more complicated question is what is the effect 
of increased buffering on SR Ca2+ content in the steady 
state? Experimental studies have found that adding ex-
ogenous cytoplasmic buffers decreases SR Ca2+.43,48 One 
explanation is that SERCA activity depends in a coop-
erative manner on [Ca2+]i,
49 whereas NCX has a linear 
dependence.50 The decreased amplitude of the systolic 
Ca2+ transient may therefore decrease SERCA activity 
more than NCX, leading to a net loss of SR Ca2+. Further 
studies are required to see if the decrease of SR content 
with increased buffering is a general phenomenon.
FACTORS THAT ALTER Ca2+ BUFFERING
Diastolic [Ca2+]i
For a simple buffer, total ([CaT]) and free ([Ca
2+]) are 
related by:
[ ] .
[ ]
[ ]
Ca B
Ca
K CaT max d
=
+
+
+
2
2
 (1)
where Bmax is the total buffer concentration and Kd is 
the concentration of Ca2+ at which 50% of the buffer 
has Ca2+ bound. The upper graph of Figure 4A shows 
such relationships for 3 values of Kd.
Buffer power (β) is defined as the change of total 
Ca2+ divided by that of free Ca.
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The individual contributions of the major indi-
vidual buffers to the total buffer power are shown in 
Figure 2Aii. At [Ca2+]i ≈100 nmol/L, the Mg
2+ sites on 
TnC make the largest contribution, whereas, at >200 
nmol/L, these are tending to saturation, and the regula-
tory site and SERCA contribute most. The lower graph 
of Figure 4A shows that buffer power has its highest 
value (equal to Bmax/Kd) at low [Ca
2+] and decreases as 
[Ca2+] increases. When [Ca2+]=Kd the buffer power is 
30% of the value at 0.1 Kd and, at 2 Kd, it is only 13% 
of this level. Consequently, the greater the diastolic 
level of [Ca2+]i, the larger will be the increase of [Ca
2+]i 
produced by a given release of total Ca from the SR.51,52 
Some appreciation of the importance of this effect is 
provided by the buffer curve of Figure 4C. Because of 
the flattening of the buffer curve at elevated [Ca2+]i, an 
increase of 60 µmol/L total [Ca2+] produces a larger in-
crease of free [Ca2+] when applied from a higher dia-
stolic [Ca2+]i than from a lower. This is clear in the simu-
lated transients of the upper graph of Figure 4D. An 
increase of diastolic [Ca2+]i of only 100 nmol/L (from 50 
to 150) increases systolic [Ca2+]i by 500 nmol/L. There-
fore, an increase of diastolic [Ca2+]i alone can lead to an 
increase of systolic, which is predicted (see lower graph 
Figure  4D) to result in a large increase of developed 
force with little change of resting force. Finally, the de-
crease of buffer power at elevated [Ca2+]i has also been 
suggested to account for a rapid initial rate of decay of 
the Ca2+ transient.54
This consequence of changes of diastolic [Ca2+]i will 
add to the inotropic effects of manoeuvers such as the 
addition of cardiac glycosides55 or β-adrenergic stimula-
tion56 that can increase diastolic [Ca2+]i. It is also a pos-
sible explanation for changes of the amplitude of the 
Ca2+ transient and force under the many conditions 
where there are no measurements of diastolic [Ca2+]i. 
Testing this will require obtaining and comparing ab-
solute measurements of [Ca2+]i between cells or tissues 
from different animals or patients. There is a dearth 
of such measurements in the literature57 because it is 
much easier to measure changes of fluorescence of a 
Ca2+-sensitive indicator than absolute levels of [Ca2+]i. 
Properly calibrated measurements, ideally using ratio-
metric indicators, are required.
Stimulation Rate
Repetitive stimulation will load slower Ca buffers (Fig-
ure  2C). This will decrease buffer power and might 
therefore increase the rise of [Ca2+]i produced by a 
given increase of total cytoplasmic Ca2+, contributing 
to the inotropic effects of increased rate.52 This effect 
is analogous to that discussed above for elevated dia-
stolic [Ca2+]i, but the slow kinetics result in a memory so 
that, following a change of rate, the effects on systolic 
[Ca2+]i and thence on the action potential duration may 
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outlast those of diastolic [Ca2+]i. Such effects may also 
contribute to the slow effects of changes of rate on 
parameters such as action potential duration.58
Buffer Kd
Equation 2 (Figure  4A) shows that, at lower values 
of [Ca2+]i, buffer power is greater the lower the value 
of Kd because this results in stronger Ca
2+ binding. 
In contrast, at higher [Ca2+]i, the lower the Kd, the 
less the buffer power as the buffers become saturat-
ed (see23 for experimental demonstration). Figure 4B 
shows the biphasic dependence of buffer power on 
Kd with the maximum being reached when Kd=[Ca
2+]i. 
Therefore, increasing buffer affinity will increase buff-
ering at diastolic levels of [Ca2+]i but decrease it at 
peak systolic ones.
One issue that has received no attention is whether 
Ca2+ buffering is the same in all cells in the ventricle. 
Given the regional differences of expression of other 
proteins including pumps59 and channels,60 heteroge-
neity of buffering would not be surprising. Likewise, 
possible variations of Ca2+ buffering between individu-
als, because of mutations and polymorphisms, do not 
appear to have been considered.
PHYSIOLOGICAL MODULATION  
OF BUFFERING
β-Adrenergic Stimulation
The 2 major Ca2+ buffers, TnC and SERCA, are regu-
lated by the phosphorylation of troponin I and phos-
pholamban, respectively, resulting in increased affinity 
Figure 4. Effects of [Ca2+]i and buffer Kd on buffer power.  
A, Effects of [Ca2+]. The top graph shows fractional saturation of a single buffer as a function of [Ca2+]. Curves are shown for 3 different values of Kd. The lower 
graph shows calculated buffer power (change of total Ca2+/change of [Ca2+]i) as a function of [Ca
2+] for these values of Kd. Colors correspond to those above. B, 
Dependence of buffer power on Kd at the 3 values of [Ca
2+] indicated. C, The effects of a small increase of diastolic [Ca2+]i on the change of systolic [Ca
2+]i pro-
duced by the addition of a fixed amount of total [Ca2+]. The buffer curve (fast buffers only) shows 2 levels of diastolic [Ca2+]i indicated as ad (50 nmol/L) and bd (150 
nmol/L). The systolic levels (respectively, as and bs) are obtained by adding 60 µmol/L total [Ca
2+] resulting in a larger increase of systolic [Ca2+]i in b compared with 
a. D, Simulation of the effect of adding and removing 60 µmol/L total Ca2+ with kinetics designed to represent a Ca2+ transient. Labels correspond to points in C. 
Upper, simulated Ca2+ transients; Lower, predicted force responses calculated using a published model.53
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of Ca2+ for SERCA61 and decreased affinity of Ca2+ for 
TnC.62 One might therefore expect that β-adrenergic 
stimulation would alter the buffer power. Experimental 
measurements, however, found no such effect,40 pos-
sibly because of 2 opposing factors: phosphorylation 
increases the affinity of Ca2+ binding to SERCA, but 
lowers it for troponin. If the Kd values are above the 
range of [Ca2+]i considered, these effects will respec-
tively increase and decrease buffer power (Figure 4A). 
Subsequent experiments, performed on transgenic 
mice in which either troponin could not be phosphory-
lated or lacking phospholamban, found the expected 
increase and decrease, respectively, of buffer power on 
phosphorylation. Further work is required to investigate 
the possibility that, in other species, the balance is less 
exact, and, therefore, phosphorylation may have a net 
effect on buffer power. As mentioned above, it should 
also be noted that the effects of a change of Ca2+ affin-
ity on buffer power will depend on the range of [Ca2+]i 
under investigation.
Effects of Changes of pH on Buffering
Many Ca2+ buffers can bind protons as an alternative to 
Ca2+ ions. Direct measurements have shown that acidi-
fication decreases Ca2+ binding to troponin.21 There-
fore, acidification will decrease the affinity for Ca2+ 
with a decrease of Ca2+ buffering power predicted at 
values of [Ca2+]i below the Kd (Figure 4B). It is surpris-
ing that intracellular acidification had no effect on Ca2+ 
buffering.63 We suggest that this may occur because, 
although a decrease of Ca2+ affinity of low-affinity buf-
fers will decrease buffer power, decreased affinity of 
very-high-affinity buffers will increase their contribution 
to buffering. Acidification has been shown to increase 
resting [Ca2+]i in rat ventricular myocytes, an effect at-
tributed to displacement of Ca2+ from buffers.15 It is not 
clear, however, why such displacement should produce 
the observed maintained increase of [Ca2+]i; one would 
expect a transient increase that decays back to baseline 
as Ca2+ is pumped out of the cell. It may result from 
the inhibition of Ca2+ efflux on NCX by acidification.64 If 
this is the case then the maintained effect on [Ca2+]i is 
presumably a consequence of the NCX effect and not 
of altered buffering. This question could be resolved by 
directly measuring the effects of pH on NCX activity.
CARDIAC DYSFUNCTION AND  
Ca2+ BUFFERING
Atrial Buffering, Fibrillation, and Failure
The total concentration of Ca2+ buffers in rat atrial myo-
cytes has been reported to be about 3 times greater 
than in ventricular myocytes with no difference in ap-
parent Kd,
65 possibly because of higher SERCA expres-
sion in the atrium than in the ventricle. Changes in 
Ca2+ buffering have been suggested to be important 
in both normal and abnormal atrial function. For ex-
ample, in sheep atria, buffer power increases with age 
because of an increase of Ca2+ affinity of the buffers.66 
This decreased both the amplitude and rate of decay of 
the systolic Ca2+ transient. Atrial myocytes from many 
species, including rabbits and cats, have few or no t-
tubules (67 for review) and the systolic Ca2+ transient 
begins at the periphery of the cell and then propagates 
toward the center.68,69 Increasing Ca2+ buffering by in-
corporation of EGTA can prevent this propagation.70 A 
modeling study also predicted this inhibitory effect of 
high buffer concentrations but pointed out that lower 
concentrations of mobile buffers such as ATP facilitate 
propagation.30 Greiser et al71 investigated the effects of 
rapid atrial pacing in rabbits to mimic the effects of atri-
al fibrillation. This resulted in a 2- to 3-fold increase of 
buffering power, at least in part, because of decreased 
phosphorylation of troponin I which was accompanied 
by (Figure 5A) decreased centripetal propagation. Evi-
dence for a causal link between increased buffering and 
decreased propagation was provided by showing that 
incorporation of BAPTA to increase buffering mimicked 
the effect on propagation. The effects of rapid pacing 
to induce heart failure have also been studied on sheep 
atrial myocytes where a decrease of buffer power was 
observed.74 This was accompanied by a decrease of the 
amplitude of the central calcium transient attributed to 
the loss of transverse tubules rather than a change of 
buffering.75 A similar decrease of calcium buffering in 
the sheep has been observed during atrial fibrillation 
where it was suggested to lead to arrhythmogenic Ca2+ 
waves, thereby contributing to atrial fibrillation.76 More 
work is required on changes of atrial Ca2+ buffering and 
their importance in atrial function. Finally, it is worth 
noting that the atrial studies reviewed above could not 
exclude the effects of small changes of end-diastolic 
[Ca2+]i on the measured buffer power.
Ca2+ Buffering and Heart Failure
Ca2+ buffering is unaffected by pacing-induced heart 
failure in both dogs77 and sheep.78 In contrast, in 
samples from human ventricle, the Ca2+ sensitivity of 
contraction was increased in dilated cardiomyopathy, 
possibly because of the decreased phosphorylation of 
troponin I.79 Increased Ca2+ sensitivity was also found 
in canine dilated cardiomyopathy80 and mouse infarct 
models.81,82 As mentioned earlier, changes of Ca2+ sen-
sitivity of contraction do not necessarily indicate altered 
Ca2+ binding and buffering; direct measurements of 
Ca2+ binding are therefore required. Increased myofila-
ment Ca sensitivity by itself will decrease cardiac relax-
ation and thereby contribute to diastolic heart failure. In 
addition, any consequential increase of Ca2+ buffering 
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will slow the decay of [Ca2+]i, worsening relaxation. In 
contrast to the data discussed above, either the induc-
tion in rats of pressure overload–induced left ventricular 
hypertrophy or heart failure following myocardial isch-
emia resulted in a decreased Ca2+ sensitivity for activa-
tion of contraction, an effect attributed to alterations in 
troponin.83 Some of the controversies in this area have 
been reviewed.84 As far as myocardial ischemia is con-
cerned, it is well known that troponin is lost from the 
heart and, indeed, the appearance of troponin I and 
troponin T in plasma is diagnostic of cardiac damage. 
Troponin release has also been detected in myocardi-
um in conditions not associated with obvious cellular 
degeneration, but this only represents a small fraction 
(≈3%) of the total troponin85 and will not therefore sig-
nificantly affect cellular buffering.
Finally, it should be noted that many studies of heart 
failure find a decrease of SERCA expression.86 We spec-
ulate that the consequent decrease of Ca2+ buffering 
would compensate in those situations where an in-
crease of myofilament buffering is expected and wors-
en where there is a decrease. Again, it will be important 
to repeat these studies of heart failure while measuring 
buffering directly.
It is also important to reemphasize the potential 
effects (Figure 4C) of changes of diastolic [Ca2+]i and, 
thence, of buffering power on the amplitude of the 
calcium transient. A major problem here is the paucity 
Figure 5. Effects of altered buffer power.  
A, Abolition of centripetal propagation of the Ca2+ transient by rapid atrial pacing (RAP). Upper traces are linescan images. Lower records show [Ca2+]i measured 
at surface of cell (black) and in center (green). Left, Records from control. Right, Records after rapid stimulation. Reproduced from.71 B, Relaxation of contraction 
in isolated rat myocytes. Records show control (euthyroid), hypothyroid, and hypothyroid with parvalbumin expressed by gene transfer. Reproduced from.72 C, 
Left, comparison of the effects of the I79N mutation of troponin T with that of the Ca2+ sensitizing agent EMD 57033 on the relationship between pCa and force. 
Right, Effects of EMD 57033 on the occurrence of ventricular tachycardia (VT). Reproduced from Greiser et al.73
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of measurements of diastolic [Ca2+]i. It is essential that 
studies on heart failure ask the simple question: how 
accurately has diastolic [Ca2+]i been measured and can 
it be excluded that changes (for example, between ani-
mals or in disease) account for the observed changes of 
systolic [Ca2+]i?
Work from Metzger and colleagues has demon-
strated that changes of Ca2+ buffering may not simply 
be involved in the development and consequences of 
heart failure, but may also be used to treat it. They 
suggested that impaired relaxation in heart failure 
could be ameliorated by adding intracellular buffers. 
They noted that fast Ca2+ buffers slow both the rise 
and fall of [Ca2+]i and decrease the amplitude of the 
Ca2+ transient, and, instead, they advocated the use 
of parvalbumin, a skeletal muscle Ca2+ buffer. This has 
the important property that it binds Ca2+ slowly be-
cause Mg2+ has to dissociate first and, therefore, there 
is little attenuation of the peak Ca2+ transient. It will 
bind Ca2+ during diastole thereby improving diastolic 
performance. Incorporation of α-parvalbumin was 
shown to accelerate the decay of [Ca2+]i with no ef-
fect on peak [Ca2+]i and (see Figure 5B) also reversed 
the slowing of relaxation produced by experimental 
hypothyroidism72 and in the Dahl salt-sensitive rat 
model of diastolic dysfunction.87 Subsequent work 
has turned to altering the structure and thence the 
relative Ca2+ and Mg2+ affinities of parvalbumin ana-
logs to improve the effects.88,89 In general, these ef-
fects of parvalbumin highlight the potential impor-
tance of endogenous slow buffers such as the Mg2+ 
site of TnC and myosin.
Ca2+ Buffering and Hypertrophic 
Cardiomyopathy
Several studies have examined the molecular basis of 
familial hypertrophic cardiomyopathy (FHC). Much 
of this work involves the effects of mutations in thin 
filament proteins such as troponin and tropomyosin, 
which are among the causes of FHC. Robinson et al22 
showed that mutations causing hypertrophic cardio-
myopathy increased the binding affinity of Ca2+ to 
myofilaments (as assessed with a fluorescent tropo-
nin) and presumably therefore Ca2+ buffering. They 
proposed that alterations of buffering might lead to 
pathological changes of the Ca2+ transient. Troponin 
mutations were subsequently investigated in a mouse 
model of the related condition of restrictive cardio-
myopathy and the predicted decreased amplitude 
and slowed decay of the Ca2+ transient observed.23,90 
In addition, myofilament Ca2+ sensitization with EMD 
57033 mimicked the effects of troponin T mutations 
on Ca2+ buffering and the Ca2+ transient.23 A recent 
study used adenovirus to infect isolated myocytes with 
troponin or tropomyosin mutations and, again, found 
an increase of diastolic [Ca2+]i.
24 Although the above 
results would be expected from an increase of buff-
ering power, it has been reported that there is a de-
crease of SERCA expression that may also contribute.91 
This study also found that the late Na+ current inhibi-
tor ranolazine abolished the slowing of decay of the 
Ca2+ current. Although no data are available, it seems 
unlikely that ranolazine would affect Ca2+ buffering. 
It may therefore be that some of the effects of thin 
filament mutations are directly attributable to Ca2+ 
buffering, and others are a secondary consequence 
of the resulting heart failure, possibly attributable to 
decreased SERCA.
As mentioned in an earlier section, the Mg2+ sites on 
troponin are important contributors to buffering at low 
[Ca2+]i. It is therefore interesting that one of the mu-
tations associated with FHC (D145E) greatly decreases 
the affinity of Ca2+ binding to these sites.92 At first sight, 
this might appear to contrast with the association be-
tween FHC and the increased affinity reviewed above. 
These observations may be reconciled by noting that a 
decrease in affinity of the very-high-affinity Mg2+ TnC 
sites will actually increase Ca2+ buffering power in the 
systolic range of [Ca2+]i.
Ca2+ Buffering and Arrhythmias
Ventricular arrhythmias constitute a major cause of 
death in FHC.93 The Knollmann group has investigated 
the underlying mechanisms in transgenic mice. Incor-
poration of mutations in troponin T or tropomyosin 
led to ventricular tachycardia. These mutations also 
sensitized the contractile machinery to activation by 
Ca2+ (Figure 5C) with those that produced the greatest 
incidence of ventricular tachycardias and arrhythmias 
having the greatest Ca-sensitizing effect.73 A causal 
link between Ca sensitization and arrhythmogen-
esis was provided by showing both that EMD 57033 
caused arrhythmias and the contractile uncoupler 
blebbistatin decreased both Ca sensitivity of the con-
tractile machinery and arrhythmia susceptibility. These 
arrhythmias were accompanied by a shortening and 
triangulation of the action potential, and electric repo-
larization alternans, as well (see below). Subsequent 
work using myocytes derived from human-induced 
pluripotent stem cells reproduced these effects of 
increased Ca2+ buffering by myofilaments on action 
potential shape and suggested that the shortened, 
triangulated action potential could be attributable to 
increased buffering decreasing the amplitude of the 
systolic Ca2+ transient and thereby the inward (depo-
larizing) NCX current.94 Although this is an attractive 
explanation, it is also worth noting that (see above), as 
well as decreasing the amplitude of the Ca2+ transient, 
increased buffering slows decay, making it harder to 
predict the net effect of increased buffering on NCX 
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current. Another article showed that, when regular 
pacing was terminated by a pause, the next Ca2+ tran-
sient was larger than control and this effect was more 
prominent in troponin T mutations that sensitize to 
activation by Ca2+.23 This effect was attributed to a 
higher cell Ca2+ content in the mutant during stimula-
tion, with the excess Ca2+ being taken up by the SR 
such that release after a pause results in a prolonged 
action potential, increasing the probability of an ar-
rhythmogenic early afterdepolarization. Any increase 
of diastolic [Ca2+]i and consequent decrease of buffer 
power may also increase the rise of [Ca2+]i caused by 
release from the SR. In the work reviewed above, the 
increase of buffering was a consequence of genetic 
changes. Similar increases of myofilament Ca2+ sensi-
tivity have been reported following myocardial infarc-
tion81 where manoeuvers that decrease Ca2+ sensitivity 
were found to abolish ventricular tachycardia follow-
ing pauses of stimulation. As reviewed above, an in-
crease of Ca2+ buffering is proarrhythmogenic. It has 
also been shown, however, that addition of the buffer 
EGTA can prevent the propagation of arrhythmogen-
ic Ca2+ waves,95 and therefore the net effect may be 
more complicated.
The induction of alternans of the action potential 
duration by increased Ca2+ buffering attributable to 
thin filament mutations73 may be a consequence of 
the slowed decay of the Ca2+ transient, resulting in in-
complete recovery at the time of the next stimulus at 
increased rates. This would be analogous to the idea 
that the increased propensity of endocardium in com-
parison with epicardium to alternans is associated with 
a more slowly decaying Ca2+ transient because of lower 
SERCA expression.59 In contrast, a modeling study has 
predicted that increasing cytoplasmic Ca2+ buffering 
should decrease the probability of alternans occurring 
by decreasing the probability that Ca2+ released from 
the SR induces further Ca2+ release from neighboring 
release sites.96 This is consistent with the experimen-
tal demonstration, in whole mouse hearts, that addi-
tion of the buffer EGTA decreased the occurrence of 
alternans48 and may be related to the experimental 
observation that increasing cytoplasmic Ca2+ buffering 
decreases the frequency of propagating Ca2+ waves97 
and makes Ca2+ sparks terminate earlier.98 Further work 
is clearly required in understanding the relationship be-
tween Ca2+ buffering and alternans.
Why Do Cells Have Ca2+ Buffers?
A high level of Ca2+ buffering is not unique to car-
diac myocytes. For example, ≈99% of the Ca2+ en-
tering chromaffin cells binds to cytoplasmic buffers.99 
The presence of Ca2+ buffers means that much larger 
movements of total Ca2+ are required to produce a 
given change of [Ca2+]i. Given that calcium move-
ments account for up to 30% of the total energy 
consumption of the heart,100 one might wonder why 
evolution has resulted in such strong buffering. There 
are several explanations. (1) It may be an inescapable 
consequence of the fact that using Ca2+ as a second 
messenger requires high concentrations of Ca2+ bind-
ing proteins, for example, to activate contraction. (2) 
A high Ca2+ buffering may stabilize Ca2+ signaling 
by stopping an abnormal increase of [Ca2+]i in one 
part of a cell propagating throughout the cell. In this 
context, it is worth noting that (Figure 2Aii) the de-
pendence of buffer power on [Ca2+]i means that the 
buffer power is much lower in systole than diastole. 
This may help Ca2+ release during systole, but protect 
against it in diastole. (3) The need for buffering may 
relate to the low intracellular concentration of calci-
um. A diastolic concentration of 100 nmol/L equates 
to 6×1016 ions per liter corresponding to a mean dis-
tance between ions of 0.25 µm. Soeller and Cannell8 
have modeled Ca2+ fluxes into the space between the 
transverse tubule and SR (dyad). They calculated that, 
at a concentration of 100 nmol/L, each dyad would 
contain between 0.007 and 0.028 Ca2+ ions. At 10 
µmol/L, there will be between 0.7 and 2.8 ions. This 
would make it impossible to control [Ca2+]i in a stable 
manner because a single Ca2+ transported into or out 
of the space would result in an enormous fractional 
change of [Ca2+]i. As pointed out previously by Bers,
35 
at such low concentrations, chance will determine 
whether a transporter interacts with an ion. In con-
trast, if total Ca2+ is 100 times the free then there will 
be between 70 and 280 ions per cleft. (4) If troponin 
was the only buffer, then virtually all the total Ca2+ 
would be bound to troponin irrespective of its Kd. This 
would make it impossible to change force by altering 
Kd because this requires other buffers to take up a 
fraction of the total Ca.
CONCLUSIONS
The concentration of buffered calcium in cytoplasm 
is 2 orders of magnitude greater than that of the 
free concentration, and, therefore, the buffers have 
an enormous effect on calcium signaling. There is a 
need for more work investigating whether changes 
of buffer properties, either directly or secondary to 
changes of diastolic [Ca2+]i, contribute to alterations 
of calcium handling and contractility. The limited 
human data reviewed above and extrapolated from 
animal models argue that changes of Ca2+ buffer-
ing are important in determining both inotropy and 
proarrhythmic status in conditions such as cardiomy-
opathies (dilated cardiomyopathy and hypertrophic 
cardiomyopathy) and ischemic heart failure in both 
health and disease. Clarification will require more 
work on human tissue.
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